GE Healthcare’s AIR Recon DL gets US FDA Approval for 3D and Motion Insensitive Imaging Applications
GE Healthcare announced that the US Food and Drug Administration (FDA) has cleared its AIR Recon DL for 3D and PROPELLER imaging sequences. The advantages of AIR Recon DL are extended by the new features to cover all Magnetic Resonance Imaging (MRI) clinical procedures, which covers all anatomies and enables better image quality, enhanced patient […]
Continue Reading